1. 1371PFinal results of RENO study: Randomized phase II of oral vinorelbine or etoposide with cisplatin & chemo-radiation in stage III NSCLC - SLCG 10/02. (23rd October 2018) Authors: Provencio Pulla, M; de las Peñas, R; Martinez Banaclocha, N; MarsÉ Fabregat, R; Insa Molla, A; Moran, T; Sala Gonzalez, M A; Massuti Sureda, B; Mut Sanchis, P; Ortega Granados, A L; Jurado, J M; Gomez Codina, J; Artal-Cortes, A; Vazquez, F; Gutierrez Calderon, V; Diz Tain, P; Vinolas Segarra, N; ... Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1391PImmune-related adverse events (irAEs) and survival (OS) in metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immunotherapy. (23rd October 2018) Authors: Meliàn Sosa, M; Puchades, C; Mendez, J A; Torres, A; Rodrigo, C; Gimeno, G; Rama, E; Martínez-Castillo, A; Caballero Daroqui, J; Gomez Codina, J; Juan-Vidal, O; Lorente, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗